Beijing Chemclin Biotech

Beijing Chemclin Biotech is a prominent Chinese in-vitro diagnostics (IVD) company that focuses on the research, development, and commercialization of clinical immunoassay systems. The company's core strength lies in its proprietary Light-initiated Chemiluminescent Assay (LiCA) platform, which utilizes oxygen-channeling technology to provide high-precision diagnostic results. Its extensive product menu includes reagents for infectious diseases, oncology, hormones, and cardiac markers, catering primarily to secondary and tertiary hospitals in China. Listed on the Shanghai Stock Exchange STAR Market, Chemclin is recognized for its innovation in replacing imported diagnostic products with high-quality domestic alternatives. The company maintains significant R&D and manufacturing facilities in Beijing and Suzhou to support its growing market presence.